Principal Financial Group’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,976
Closed -$262K 2445
2024
Q1
$262K Buy
13,976
+352
+3% +$8.12K ﹤0.01% 2117
2023
Q4
$295K Buy
13,624
+15
+0.1% +$297 ﹤0.01% 2070
2023
Q3
$280K Sell
13,609
-138
-1% -$3.98K ﹤0.01% 2076
2023
Q2
$646K Sell
13,747
-684
-5% -$34K ﹤0.01% 1909
2023
Q1
$606K Buy
14,431
+2,155
+18% +$92.7K ﹤0.01% 1931
2022
Q4
$468K Buy
12,276
+67
+0.5% +$2.56K ﹤0.01% 1994
2022
Q3
$478K Buy
12,209
+2,862
+31% +$111K ﹤0.01% 1971
2022
Q2
$302K Buy
9,347
+2,482
+36% +$83.2K ﹤0.01% 2176
2022
Q1
$227K Sell
6,865
-175
-2% -$6.58K ﹤0.01% 2305
2021
Q4
$299K Sell
7,040
-4,903
-41% -$205K ﹤0.01% 2246
2021
Q3
$529K Sell
11,943
-5,695
-32% -$261K ﹤0.01% 2157
2021
Q2
$1M Buy
17,638
+2,176
+14% +$154K ﹤0.01% 2040
2021
Q1
$1.16M Buy
15,462
+1,464
+10% +$120K ﹤0.01% 1964
2020
Q4
$1.21M Sell
13,998
-800
-5% -$59K ﹤0.01% 1902
2020
Q3
$904K Buy
14,798
+3,308
+29% +$168K ﹤0.01% 1892
2020
Q2
$478K Buy
11,490
+3,522
+44% +$128K ﹤0.01% 1981
2020
Q1
$229K Sell
7,968
-5,176
-39% -$300K ﹤0.01% 2036
2019
Q4
$949K Sell
13,144
-271
-2% -$33.3K ﹤0.01% 1844
2019
Q3
$1.88M Sell
13,415
-543
-4% -$90.8K ﹤0.01% 1729
2019
Q2
$2.56M Buy
13,958
+1,076
+8% +$184K ﹤0.01% 1690
2019
Q1
$2.05M Sell
12,882
-10,320
-44% -$1.49M ﹤0.01% 1733
2018
Q4
$2.22M Buy
23,202
+243
+1% +$27.8K ﹤0.01% 1703
2018
Q3
$3.24M Buy
22,959
+862
+4% +$133K ﹤0.01% 1697
2018
Q2
$3.46M Buy
22,097
+9,691
+78% +$1.52M ﹤0.01% 1676
2018
Q1
$2M Buy
12,406
+382
+3% +$64.9K ﹤0.01% 1738
2017
Q4
$1.98M Buy
12,024
+6,661
+124% +$646K ﹤0.01% 1756
2017
Q3
$334K Sell
5,363
-963
-15% -$75.6K ﹤0.01% 2007
2017
Q2
$504K Buy
6,326
+703
+13% +$50.8K ﹤0.01% 1946
2017
Q1
$400K Buy
5,623
+62
+1% +$3.63K ﹤0.01% 1955
2016
Q4
$284K Buy
5,561
+847
+18% +$39.9K ﹤0.01% 2024
2016
Q3
$217K Buy
+4,714
New +$192K ﹤0.01% 2027

Other funds holding SAGE